Profile data is unavailable for this security.
About the company
AnteoTech Ltd is an Australia-based supplier of advanced material solutions to the battery materials and life sciences markets. Its products and technologies include Anteo X, Ultranode, AnteoBind and AnteoBind NXT. Anteo X is a water-based, binder-compatible cross linker designed to improve the mechanical stability and performance of high silicon anodes in lithium-ion batteries. Anteo X enhances cohesion between active materials, binders, and conductive agents, enabling higher silicon loadings, greater energy density, and improved cycle life. Ultranode is its proprietary high silicon anode formulation technology, developed to boost energy density in lithium-ion batteries. AnteoBind is a patented surface chemistry platform that simplifies and enhances the immobilization (bioconjugation) of biomolecules on a variety of substrates. AnteoBind NXT builds on the core AnteoBind technology, delivering improved binding efficiency, and reducing reagent usage.
- Revenue in AUD (TTM)1.03m
- Net income in AUD-6.76m
- Incorporated1995
- Employees40.00
- LocationAnteotech LtdBrisbane Technology ParkSE 4 26 Brandl StEIGHT MILE PLAINS 4113AustraliaAUS
- Phone+61 73219-0085
- Fax+61 73219-0553
- Websitehttps://www.anteotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurotech International Ltd | 2.58m | -10.60m | 19.44m | -- | -- | 5.33 | -- | 7.53 | -0.0103 | -0.0103 | 0.0025 | 0.0028 | 0.3341 | -- | 12.69 | -- | -137.17 | -130.68 | -142.71 | -148.27 | 4.41 | -- | -410.57 | -428.93 | 11.34 | -- | 0.00 | -- | -22.61 | 99.30 | -109.08 | -- | -- | -- |
| Noxopharm Ltd | 2.83m | -4.88m | 19.58m | 1.00k | -- | 28.38 | -- | 6.92 | -0.0167 | -0.0167 | 0.0097 | 0.0024 | 0.4979 | -- | 1.06 | -- | -85.95 | -49.70 | -156.33 | -59.16 | -- | -- | -172.63 | -229.01 | -- | -- | 0.7823 | -- | 17.54 | -19.45 | -36.50 | -- | -- | -- |
| IDT Australia Ltd | 19.86m | -8.06m | 20.94m | 156.00 | -- | 0.962 | -- | 1.05 | -0.0189 | -0.0189 | 0.0465 | 0.0509 | 0.5817 | 2.60 | 2.59 | -- | -23.61 | -13.43 | -29.19 | -16.06 | 69.19 | 79.42 | -40.60 | -30.01 | 2.36 | -9.62 | 0.3222 | -- | 40.65 | 6.99 | -48.96 | -- | 11.30 | -- |
| BTC Health Ltd | 9.96k | 3.98m | 23.23m | 1.00 | 5.58 | 2.31 | 5.84 | 2,332.79 | 0.0117 | 0.0117 | 0.00003 | 0.0282 | 0.0014 | -- | -- | -- | 54.89 | -13.71 | 56.47 | -14.66 | -- | -- | 39,972.79 | -3,966.34 | -- | -- | 0.00 | -- | -39.12 | -43.28 | 277.27 | -- | -- | -- |
| Holista Colltech Limited | 5.83m | 584.85k | 31.27m | 3.00 | 38.64 | -- | 48.35 | 5.36 | 0.0022 | 0.0023 | 0.0195 | -0.0016 | 1.76 | 3.83 | 5.84 | -- | 17.53 | -46.13 | -- | -85.40 | 49.66 | 55.15 | 9.98 | -38.85 | 0.3782 | 3.93 | -- | -- | -5.82 | -5.07 | 97.92 | -- | -37.01 | -- |
| Argenica Therapeutics Ltd | 512.75k | -7.17m | 37.89m | -- | -- | 5.24 | -- | 73.90 | -0.0559 | -0.0559 | 0.004 | 0.0564 | 0.0374 | -- | 1.29 | -- | -52.31 | -47.11 | -67.68 | -55.90 | -- | -- | -1,398.41 | -2,938.71 | -- | -20,767.20 | 0.00 | -- | 166.93 | 359.61 | -30.86 | -- | -- | -- |
| Anteotech Ltd | 1.03m | -6.76m | 38.65m | 40.00 | -- | 11.16 | -- | 37.61 | -0.0025 | -0.0025 | 0.0004 | 0.0012 | 0.1299 | -- | 6.90 | -- | -85.41 | -76.84 | -106.22 | -87.65 | -- | -- | -657.69 | -1,253.69 | -- | -- | 0.3835 | -- | 99.60 | 27.97 | 23.89 | -- | -4.02 | -- |
| Algorae Pharmaceuticals Ltd | 141.05k | -802.96k | 40.53m | -- | -- | 18.17 | -- | 287.35 | -0.0005 | -0.0005 | 0.00008 | 0.0013 | 0.0505 | -- | 3.38 | -- | -28.72 | -51.95 | -30.63 | -56.76 | -- | -- | -569.27 | -1,452.78 | -- | -- | 0.00 | -- | 12.66 | -23.93 | 61.68 | -- | -- | -- |
| Emyria Ltd | 1.39m | -3.14m | 43.55m | -- | -- | 6.22 | -- | 31.23 | -0.0069 | -0.0069 | 0.0031 | 0.0087 | 0.2316 | -- | 40.72 | -- | -52.19 | -82.51 | -69.83 | -106.69 | 1.76 | -17.98 | -225.33 | -355.61 | -- | -22.44 | 0.1037 | -- | -36.68 | 6.60 | 72.57 | -- | -41.45 | -- |
| Neuroscientific Biopharmaceuticals Ltd | 166.08k | -1.85m | 46.56m | -- | -- | 2.77 | -- | 280.35 | -0.0126 | -0.0126 | 0.0011 | 0.0506 | 0.0148 | -- | 2.17 | -- | -16.48 | -37.13 | -16.65 | -40.11 | -- | -- | -1,111.22 | -185.57 | -- | -746.17 | 0.00 | -- | -93.05 | 16.84 | -669.23 | -- | -- | -- |
| Entropy Neurodynamics Ltd | 1.59m | -5.33m | 48.49m | -- | -- | 7.48 | -- | 30.54 | -0.0043 | -0.0043 | 0.0012 | 0.0041 | 0.2249 | -- | 0.763 | -- | -75.55 | -- | -92.06 | -- | -- | -- | -335.91 | -- | -- | -100.79 | 0.00 | -- | -- | -10.25 | -- | -- | -26.73 | -- |
| Syntara Ltd | 7.48m | -12.26m | 55.52m | 107.00 | -- | 3.45 | -- | 7.42 | -0.0084 | -0.0054 | 0.0051 | 0.0099 | 0.4701 | -- | 2.53 | -- | -77.03 | -36.39 | -116.54 | -50.26 | -- | -- | -163.86 | -78.37 | -- | -953.38 | 0.0052 | -- | 37.80 | -9.83 | 10.31 | -- | -- | -- |
